OBJECTIVE: Cognitive impairments are prevalent in heart failure (HF) patients, worsening outcomes but often undetected.The aim of this study was to screen HF outpatients for mild cognitive impairment (MCI), determine the areas of cognition affected, patient awareness of cognitive change, and associated factors. METHOD AND RESULTS: HF patients (n = 128) newly registered for the Management of Cardiac Function program, free from neurocognitive disorder, and with sufficient visual acuity were assessed with the use of the Montreal Cognitive Assessment tool (MoCA). MCI was classified as MoCA score ≤22. The sample was elderly (mean, 80.65 years; SD, 11.52). Mean MoCA score was 24.58 (SD 3.45), 22% were classified as impaired, 45% had noticed a change in cognition, and 15% reported that they were affected in their daily lives. Patients noticing this impact had lower MoCA scores (22.74, SD 3.0) than those who did not (25.17, SD 2.96; P ≤ .02). Most impairments occurred for delayed recall, visuospatial/executive function, and abstraction. The odds of impairment increased by the presence of ischemic heart disease (odds ratio, 4.18; 95% confidence interval, 1.15-15.69). CONCLUSIONS: In HF outpatients without a dementia diagnosis, MCI is prevalent. Screening for MCI and incorporation of compensatory strategies are essential.
OBJECTIVE:Cognitive impairments are prevalent in heart failure (HF) patients, worsening outcomes but often undetected.The aim of this study was to screen HF outpatients for mild cognitive impairment (MCI), determine the areas of cognition affected, patient awareness of cognitive change, and associated factors. METHOD AND RESULTS: HF patients (n = 128) newly registered for the Management of Cardiac Function program, free from neurocognitive disorder, and with sufficient visual acuity were assessed with the use of the Montreal Cognitive Assessment tool (MoCA). MCI was classified as MoCA score ≤22. The sample was elderly (mean, 80.65 years; SD, 11.52). Mean MoCA score was 24.58 (SD 3.45), 22% were classified as impaired, 45% had noticed a change in cognition, and 15% reported that they were affected in their daily lives. Patients noticing this impact had lower MoCA scores (22.74, SD 3.0) than those who did not (25.17, SD 2.96; P ≤ .02). Most impairments occurred for delayed recall, visuospatial/executive function, and abstraction. The odds of impairment increased by the presence of ischemic heart disease (odds ratio, 4.18; 95% confidence interval, 1.15-15.69). CONCLUSIONS: In HF outpatients without a dementia diagnosis, MCI is prevalent. Screening for MCI and incorporation of compensatory strategies are essential.
Authors: Emily C Gathright; Mary A Dolansky; John Gunstad; Richard A Josephson; Shirley M Moore; Joel W Hughes Journal: Eur J Cardiovasc Nurs Date: 2019-07-25 Impact factor: 3.908
Authors: Monirah Albabtain; Michael J Brenner; John M Nicklas; Scott L Hummel; Michael P McCormick; Jeffrey L Pawlowski; Tami L Remington; Tanya R Gure; Michael P Dorsch; Barry E Bleske Journal: Med Sci Monit Date: 2016-12-18
Authors: Cubby L Gardner; Fang Liu; Paul Fontelo; Michael C Flanagan; Albert Hoang; Harry B Burke Journal: BMC Med Inform Decis Mak Date: 2017-04-14 Impact factor: 2.796
Authors: Amy M Pastva; Christina E Hugenschmidt; Dalane W Kitzman; M Benjamin Nelson; Gretchen A Brenes; Gordon R Reeves; Robert J Mentz; David J Whellan; Haiying Chen; Pamela W Duncan Journal: J Card Fail Date: 2020-09-18 Impact factor: 5.712
Authors: Miriam J Johnson; Sarah Cockayne; David C Currow; Kerry Bell; Kate Hicks; Caroline Fairhurst; Rhian Gabe; David Torgerson; Laura Jefferson; Stephen Oxberry; Justin Ghosh; Karen J Hogg; Jeremy Murphy; Victoria Allgar; John G F Cleland; Andrew L Clark Journal: ESC Heart Fail Date: 2019-08-06